The shingles vaccine is not a lifelong immunization; according to studies, the shingles vaccine provides protection for about 9 years. According to clinical trial studies, the shingles vaccine can effectively induce the body to produce cellular and humoral immune response, which can be maintained at a certain level up to about 9 years in elderly people of different ages. The main symptoms of herpes zoster are localized pain, rash and acute neuritis, and the harm lies in the irreversible damage to the peripheral nerves, which can cause persistent post-herpetic neuralgia and affect the patient’s life. Herpes zoster vaccine is approved for use in China for the prevention of herpes zoster disease in elderly people aged 50 years and above, and cannot be used for the prevention of chickenpox, the protection effect is good, the main adverse reactions include pain at the site of vaccination, redness, myalgia, fatigue, headache, etc., and is contraindicated for those who are allergic to the vaccine. Therefore, it is recommended that eligible people complete the vaccination in time to prevent the occurrence of shingles.